Eslicarbazepine Acetate (BIA 2-093): Relative Bioavailability and Bioequivalence of 50 mg/mL Oral Suspension and 200mg and 800mg Tablet Formulations
Year: 2005
Type: article
Study design: Clinical Trial
Source: Drugs in R&D
Authors: Carlos Fontes-Ribeiro, Teresa Nunes, Amilcar Falc??o, Carla Neta, Ricardo Lima, Susana Tavares, Luis Almeida, Tice Macedo, Patricio Soares-da-Silva
Institution: Bial (Portugal)
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1976554010